Abstract
Many of the immunological methods currently used in laboratory testing for cancer are based on the use of antibodies, including many diagnostic and prognostic tests, as well as some tests intended to inform treatment decisions. Unlocking the genetics of antibodies (Abs) has allowed researchers to manipulate their structure and harness the immense array of possible specificities granted to the immune system by evolution. The platforms that rely on Abs for detection are numerous and include enzyme-linked immunosorbent assays (ELISA), flow cytometry, radioimmunoassay (RIA), immunohistochemistry and immunocytochemistry (IHC/ICC), and Ab arrays. Here we will provide a brief background on the ways in which the immunoglobulin protein can be manipulated and used as a tool for the detection of targets of interest. In addition, we will describe the principles behind many of the immunological methods used in testing in patients with cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ricart AD, Tolcher AW. Technology insight: cytotoxic drug immunoconjugates for cancer therapy. Nat Clin Pract Oncol. 2007;4(4):245–55.
Sofou S, Sgouros G. Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin Drug Deliv. 2008;5(2):189–204.
Tanaka K, Fukase K. PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics. Org Biomol Chem. 2008;6(5):815–28.
van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR. Immuno-PET: a navigator in monoclonal antibody development and applications. Oncologist. 2007;12(12):1379–89.
Weber WA, Czernin J, Phelps ME, Herschman HR. Technology insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Nat Clin Pract Oncol. 2008;5(1):44–54.
Cooper HM, Paterson Y. Production of polyclonal antisera. Curr Protoc Mol Biol. 2008. Chapter 11:Unit 11.12.
Mechetner E. Development and characterization of mouse hybridomas. In: Albitar M, editor. Monoclonal antibodies: methods and protocols. Totowa: Humana Press; 2007. p. 1–13.
Zhang ZJ, Albitar M. Monoclonal antibodies. In: Walker JM, Rapley R, editors. Molecular biomethods handbook. 2nd ed. Totowa: Humana Press; 2008. p. 547–61.
Donzeau M, Knappik A. Recombinant monoclonal antibodies. In: Albitar M, editor. Monoclonal antibodies: methods and protocols. Totowa: Humana Press; 2007. p. 15–31.
Haugland RP. Antibody conjugates for cell biology. Curr Protoc Cell Biol. 2001. Chapter 16:Unit 16.5.
Hirsch JD, Haugland RP. Conjugation of antibodies to biotin. Methods Mol Biol. 2005;295:135–54.
Haugland RP, Bhalgat MK. Preparation of avidin conjugates. Methods Mol Biol. 2008;418:1–12.
Bonifacino JS, Dell’Angelica EC, Springer TA. Immunoprecipitation. Curr Protoc Immunol. 2001. Chapter 8:Unit 8.3.
Gallagher S, Winston SE, Fuller SA, Hurrell JG. Immunoblotting and immunodetection. Curr Protoc Mol Biol. 2004. Chapter 10:Unit 10.8.
Zamrazilova L, Kazihnitkova H, Lapcik O, Hill M, Hampl R. A novel radioimmunoassay of 16alpha-hydroxy-dehydroepiandrosterone and its physiological levels. J Steroid Biochem Mol Biol. 2007;104(3–5):130–5.
Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960;39:1157–75.
Hornbeck P. Enzyme-linked immunosorbent assays. Curr Protoc Immunol. 2001. Chapter 2:Unit 2.1.
Bulanova E, Budagian V, Duitman E, Orinska Z, Krause H, Ruckert R, et al. Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J Biol Chem. 2007;282(18):13167–79.
Kocinsky HS, Girardi AC, Biemesderfer D, Nguyen T, Mentone S, Orlowski J, et al. Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol. 2005;289(2):F249–58.
Liang Z, Wong RP, Li LH, Jiang H, Xiao H, Li G. Development of pan-specific antibody against trimethyllysine for protein research. Proteome Sci. 2008;6:2.
Spoettl T, Hausmann M, Klebl F, Dirmeier A, Klump B, Hoffmann J, et al. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm Bowel Dis. 2007;13(6):727–32.
Sumbayev VV, Yasinska IM. Protein S-nitrosation in signal transduction: assays for specific qualitative and quantitative analysis. Methods Enzymol. 2008;440:209–19.
Takada K, Nasu H, Hibi N, Tsukada Y, Ohkawa K, Fujimuro M, et al. Immunoassay for the quantification of intracellular multi-ubiquitin chains. Eur J Biochem. 1995;233(1):42–7.
Hofman F. Immunohistochemistry. Curr Protoc Immunol. 2002. Chapter 21:Unit 21.4.
Polak JM, Van Noorden S. Introduction to immunocytochemistry. 3rd ed. Oxford: BIOS Scientific Publishers Ltd; 2002.
Sharrow SO. Overview of flow cytometry. Curr Protoc Immunol. 2002; Chapter 5: Unit 5 1
Darzynkiewicz Z, Huang X. Analysis of cellular DNA content by flow cytometry. Curr Protoc Immunol. 2004. Chapter 5:Unit 5.7.
Donahue AC, Fruman DA. Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur J Immunol. 2007;37(10):2923–36.
Donahue AC, Kharas MG, Fruman DA. Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes. Methods Enzymol. 2007;434:131–54.
Foster B, Prussin C, Liu F, Whitmire JK, Whitton JL. Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol. 2007. Chapter 6:Unit 6.24.
June CH, Moore JS. Measurement of intracellular ions by flow cytometry. Curr Protoc Immunol. 2004. Chapter 5:Unit 5.5.
Schulz KR, Danna EA, Krutzik PO, Nolan GP. Single-cell phospho-protein analysis by flow cytometry. Curr Protoc Immunol. 2007. Chapter 8:Unit 8.17.
Irish JM, Czerwinski DK, Nolan GP, Levy R. Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J Immunol. 2006;177(3):1581–9.
Krutzik PO, Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods. 2006;3(5):361–8.
Jilani I, Kantarjian H, Faraji H, Gorre M, Cortes J, Ottmann O, et al. An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation. Leuk Res. 2008;32(6):936–43.
Jilani I, Kantarjian H, Gorre M, Cortes J, Ottmann O, Bhalla K, et al. Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy. Leuk Res. 2008;32(4):643–9.
Kellar KL, Douglass JP. Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J Immunol Methods. 2003;279(1–2):277–85.
Gu AD, Xie YB, Mo HY, Jia WH, Li MY, Li M, et al. Antibodies against Epstein-Barr virus gp78 antigen: a novel marker for serological diagnosis of nasopharyngeal carcinoma detected by xMAP technology. J Gen Virol. 2008;89(Pt 5):1152–8.
Borrebaeck CA, Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Rev Mol Diagn. 2007;7(5):673–86.
Haab BB. Antibody arrays in cancer research. Mol Cell Proteomics. 2005;4(4):377–83.
Jaras K, Ressine A, Nilsson E, Malm J, Marko-Varga G, Lilja H, et al. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective. Anal Chem. 2007;79(15):5817–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Donahue, A.C., Peng, Yl. (2015). Principles of Immunological Diagnostic Tests for Cancers. In: Rezaei, N. (eds) Cancer Immunology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44006-3_24
Download citation
DOI: https://doi.org/10.1007/978-3-662-44006-3_24
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44005-6
Online ISBN: 978-3-662-44006-3
eBook Packages: MedicineMedicine (R0)